Vaginal cancer mortality statistics

Deaths

Deaths from vaginal cancer, 2017-2019, UK.

Proportion of all deaths

Percentage vaginal cancer contributes to total cancer deaths, 2017-2019, UK

Age

Peak mortality rate for vaginal cancer, 2017-2019, UK

Trend over time

Change in vaginal cancer mortality rates since the early 1970s, Females, UK

Vaginal cancer is not among the 20 most common causes of cancer death in females in the UK, accounting for less than 1% of all cancer deaths in females (2017-2019). In females and males combined, vaginal cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2017-2019).[1-4]

Vaginal cancer mortality rates (European age-standardised Open a glossary item (AS) rates) for females are significantly higher than the UK average in Scotland, and similar to the UK average in all other UK constituent countries.

For vaginal cancer there are mortality differences between countries despite there being no such differences in incidence.

Vaginal Cancer (C52), Annual Average Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Female Population, UK, 2017-2019

  England Scotland Wales Northern Ireland UK
Female Deaths 87 15 6 3 110
Crude Rate 0.3 0.5 0.4 0.3 0.3
AS Rate 0.3 0.5 0.3 0.3 0.3
AS Rate - 95% LCL 0.3 0.4 0.2 0.1 0.3
AS Rate - 95% UCL 0.3 0.7 0.5 0.6 0.4
Persons Deaths 87 15 6 3 110
Crude Rate 0.2 0.3 0.2 0.2 0.2
AS Rate 0.2 0.3 0.2 0.2 0.2
AS Rate - 95% LCL 0.1 0.2 0.1 0.1 0.2
AS Rate - 95% UCL 0.2 0.4 0.3 0.3 0.2
95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, C52.

Last reviewed:

Vaginal cancer mortality is strongly related to age, with the highest mortality rates being in older women. In the UK in 2017-2019, on average each year half of deaths (50%) were in females aged 75 and over.[1-4] This largely reflects higher incidence and lower survival for vaginal cancer in older people.

Age-specific mortality rates rise steadily from around age 35-39 and more steeply from around age 60-64. The highest rates are in the 90+ age group.

Vaginal Cancer (C52), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Female Population, UK, 2017-2019

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, ICD-10 C52.

Last reviewed:

Vaginal cancer age-standardised (AS) Open a glossary itemrates for females decreased by 47% in the UK between 1971-1973 and 2017-2019.

Over the last decade in the UK (between 2007-2009 and 2017-2019), vaginal cancer AS mortality rates for females remained stable.

Vaginal Cancer (C52), European Age-Standardised Mortality Rates per 100,000 Female Population, UK, 1971-2019

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Vaginal cancer mortality rates have decreased overall in some broad age groups in females in the UK since the early 1970s, but have remained stable in others.[1-4] Rates in 0-24s have remained stable, in 25-49s have remained stable, in 50-59s have decreased by 49%, in 60-69s have decreased by 41%, in 70-79s have decreased by 46% and in 80+s have decreased by 52%.

Vaginal Cancer (C52), European Age-Standardised Mortality Rates per 100,000 Female Population, By Age, UK, 1971-2019

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 1971-2019, C52.

Cancers in children and young people (aged 0-24) are best classified using a different system to cancers in adults, so the figures presented here may not correspond with those elsewhere.

Last reviewed:

There is evidence for an association between vaginal cancer mortality and deprivation in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 75% higher for females living in the most deprived areas compared with the least deprived.[1]

Vaginal Cancer (C52), European Age-Standardised Mortality Rates by Deprivation Quintile, Females, England, 2007-2011

The estimated deprivation gradient in vaginal cancer mortality between females living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 20 fewer cancer deaths each year in England during 2007-2011 if all females experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C52

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.